The Moroccan Federation of Pharmaceutical Industry and Innovation (FMIIP) recently began a cycle of discussions with national political forces as well as civil society, in order to share its strategy for the development of local manufacturing, indicates the federation in a statement. The objective is to discuss with the various political actors as well as the associative fabric on the ways and means to develop the national health system, strengthen the health and therapeutic sovereignty, improve the service provided to the patient and strengthen the competitiveness of the industrial fabric. national drug, adds the same source. This exchange platform comes at a fundamental moment when the national community is strongly challenged on the need to guarantee the robustness of the health system while contributing to the increase in added value on national soil, in order to generate more jobs in the sector and improve access to medicines by the populations, specifies the FMIIP. In addition, this action is part of the participatory approach of the Federation, which aims to position the sector as one of the flagships of the national industry, at the service of patients, and also intends to involve all of the country’s forces. in its forward-looking approach and propose concrete solutions to the challenge of expanding social protection, the fight against the pandemic and economic recovery, while ultimately building an export industry with a Euro-African vocation. First association in the sector, founded in 1985, the FMIIP has been committed for more than 35 years to the development of the national pharmaceutical industry and brings together the main Moroccan laboratories, and multinationals with production sites of drugs in the country. FMIIP members also represent more than 260 foreign groups. Remember that the FMIIP was co-opted by the General Confederation of Moroccan Enterprises (CGEM) as an external statutory sector federation on January 15.